Secondary preventive medication persistence and adherence 1 year after stroke.

ABSTRACT:

Objective

Data on long-term use of secondary prevention medications following stroke are limited. The Adherence eValuation After Ischemic stroke-Longitudinal (AVAIL) Registry assessed patient, provider, and system-level factors influencing continuation of prevention medications for 1 year following stroke hospitalization discharge.

Methods

Patients with ischemic stroke or TIA discharged from 106 hospitals participating in the American Heart Association Get With The Guidelines-Stroke program were surveyed to determine their use of warfarin, antiplatelet, antihypertensive, lipid-lowering, and diabetes medications from discharge to 12 months. Reasons for stopping medications were ascertained. Persistence was defined as continuation of all secondary preventive medications prescr

SUBMITTER: Bushnell CD 

PROVIDER: S-EPMC3265047 | biostudies-literature | 2011 Sep

REPOSITORIES: biostudies-literature